Access cutting-edge fanconi anemia treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access fanconi anemia specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fanconi anemia treatment provided free
The purpose of this study is to determine whether the use of lower doses of busulfan and the elimination of cyclosporine will further reduce transplant-related side effects for patients with Fanconi Anemia (FA). Patients will undergo a transplant utilizing mis-matched related or matched unrelated donors following a preparative regimen of busulfan, fludarabine, anti-thymocyte globulin and cyclophosphamide.
Sponsor: Children's Hospital Medical Center, Cincinnati
Check if you qualify for this fanconi anemia clinical trial in New York, NY
If you're searching for fanconi anemia treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fanconi anemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.